These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 3104387)
1. Gonadotropins and testosterone escape from suppression during prolonged luteinizing hormone-releasing hormone antagonist administration in normal men. Pavlou SN; Interlandi JW; Wakefield G; Island DP; Rivier J; Vale W; Kovacs WJ J Clin Endocrinol Metab; 1987 May; 64(5):1070-4. PubMed ID: 3104387 [TBL] [Abstract][Full Text] [Related]
2. Single subcutaneous doses of a luteinizing hormone-releasing hormone antagonist suppress serum gonadotropin and testosterone levels in normal men. Pavlou SN; Debold CR; Island DP; Wakefield G; Rivier J; Vale W; Rabin D J Clin Endocrinol Metab; 1986 Aug; 63(2):303-8. PubMed ID: 3088019 [TBL] [Abstract][Full Text] [Related]
3. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men. Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334 [TBL] [Abstract][Full Text] [Related]
4. Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men. Pavlou SN; Wakefield GB; Island DP; Hoffman PG; LePage ME; Chan RL; Nerenberg CA; Kovacs WJ J Clin Endocrinol Metab; 1987 May; 64(5):931-6. PubMed ID: 3104388 [TBL] [Abstract][Full Text] [Related]
5. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men. Pavlou SN; Veldhuis JD; Lindner J; Souza KH; Urban RJ; Rivier JE; Vale WW; Stallard DJ J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578 [TBL] [Abstract][Full Text] [Related]
6. Suppression of plasma gonadotropins and testosterone in adult male monkeys (Macaca fascicularis) by a potent inhibitory analog of gonadotropin-releasing hormone. Adams LA; Bremner WJ; Nestor JJ; Vickery BH; Steiner RA J Clin Endocrinol Metab; 1986 Jan; 62(1):58-63. PubMed ID: 3079603 [TBL] [Abstract][Full Text] [Related]
7. Compensatory response of the luteinizing-hormone (LH)-releasing hormone (LHRH)/LH pulse generator after administration of a potent LHRH antagonist in the ram. Lincoln GA; Fraser HM Endocrinology; 1987 Jun; 120(6):2245-50. PubMed ID: 3032581 [TBL] [Abstract][Full Text] [Related]
8. Gonadotropin and steroid secretory patterns during chronic treatment with a luteinizing hormone-releasing hormone agonist analog in men. Evans RM; Doelle GC; Alexander AN; Uderman HD; Rabin D J Clin Endocrinol Metab; 1984 May; 58(5):862-7. PubMed ID: 6423661 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of serum luteinizing hormone and testosterone with an inhibitory analog of luteinizing hormone-releasing hormone in adult male rhesus monkeys. Burgos-Briceño LA; Schally AV; Bartke A; Asch RH J Clin Endocrinol Metab; 1984 Oct; 59(4):601-7. PubMed ID: 6384248 [TBL] [Abstract][Full Text] [Related]
10. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix). Andreyko JL; Monroe SE; Marshall LA; Fluker MR; Nerenberg CA; Jaffe RB J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507 [TBL] [Abstract][Full Text] [Related]
11. Comparative effects of two different delivery systems on gonadotropin-releasing hormone (GnRH) antagonist-induced suppression of gonadotropins and testosterone in man. Salameh W; Bhasin S; Steiner BS; McAdams LA; Peterson M; Rivier JE; Vale WW; Swerdloff RS J Androl; 1994; 15(1):22-8. PubMed ID: 8188535 [TBL] [Abstract][Full Text] [Related]
12. The luteinizing hormone-releasing hormone (LHRH) agonist [D-Trp6-Pro9-NEt]LHRH increased rather than lowered LH and alpha-subunit levels in a patient with an LH-secreting pituitary tumor. Roman SH; Goldstein M; Kourides IA; Comite F; Bardin CW; Krieger DT J Clin Endocrinol Metab; 1984 Feb; 58(2):313-9. PubMed ID: 6198331 [TBL] [Abstract][Full Text] [Related]
13. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate. Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948 [TBL] [Abstract][Full Text] [Related]
14. High loading and low maintenance doses of a gonadotropin-releasing hormone antagonist effectively suppress serum luteinizing hormone, follicle-stimulating hormone, and testosterone in normal men. Behre HM; Kliesch S; Pühse G; Reissmann T; Nieschlag E J Clin Endocrinol Metab; 1997 May; 82(5):1403-8. PubMed ID: 9141524 [TBL] [Abstract][Full Text] [Related]
15. Suppression of luteal function by a luteinizing hormone-releasing hormone antagonist during the early luteal phase in the stumptailed macaque monkey and the effects of subsequent administration of human chorionic gonadotropin. Fraser HM; Nestor JJ; Vickery BH Endocrinology; 1987 Aug; 121(2):612-8. PubMed ID: 3109885 [TBL] [Abstract][Full Text] [Related]
16. The dynamics of gonadotropin inhibition in women induced by an antagonistic analog of gonadotropin-releasing hormone. Cetel NS; Rivier J; Vale W; Yen SS J Clin Endocrinol Metab; 1983 Jul; 57(1):62-5. PubMed ID: 6406535 [TBL] [Abstract][Full Text] [Related]
17. Differential control of luteinizing hormone and follicle-stimulating hormone secretion by luteinizing hormone-releasing hormone pulse frequency in man. Gross KM; Matsumoto AM; Bremner WJ J Clin Endocrinol Metab; 1987 Apr; 64(4):675-80. PubMed ID: 3102545 [TBL] [Abstract][Full Text] [Related]
18. A comparison of the suppressive effects of testosterone and a potent new gonadotropin-releasing hormone antagonist on gonadotropin and inhibin levels in normal men. Bagatell CJ; McLachlan RI; de Kretser DM; Burger HG; Vale WW; Rivier JE; Bremner WJ J Clin Endocrinol Metab; 1989 Jul; 69(1):43-8. PubMed ID: 2499592 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of luteinizing hormone, follicle-stimulating hormone and sex-steroid levels in men and women with a potent antagonist analog of luteinizing hormone-releasing hormone, Cetrorelix (SB-75). Gonzalez-Barcena D; Vadillo Buenfil M; Garcia Procel E; Guerra-Arguero L; Cardenas Cornejo I; Comaru-Schally AM; Schally AV Eur J Endocrinol; 1994 Sep; 131(3):286-92. PubMed ID: 7921214 [TBL] [Abstract][Full Text] [Related]
20. Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist cetrorelix (SB-75) in normal men. Behre HM; Klein B; Steinmeyer E; McGregor GP; Voigt K; Nieschlag E J Clin Endocrinol Metab; 1992 Aug; 75(2):393-8. PubMed ID: 1639941 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]